Omeros Corporation

OMER · Moat type: REGULIERUNG

MoatScore

0/10

Fair Value

4 USD

Margin of Safety

-131.0 %

Rating

MEIDEN

Omeros Corporation is a clinical biopharmaceutical company specializing in the development and commercialization of therapeutics for inflammatory and CNS-related diseases, generating revenues primarily from product sales as well as licensing and milestone payments.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.